top bar
Nitto
Avecia Logo
banner

Extensive Experience, Comprehensive Services

For over 20 years, Avecia has used technical expertise and unmatched experience in oligonucleotide production to provide exceptional service. Our commitment to flexible solutions and innovative ideas drives us to continue to meet and exceed the needs of our customers and the oligonucleotide therapeutic market.

New for 2013: Avecia continues to grow with both the acquisition of Girindus America’s CMO business and the launch of our new pre-clinical oligonucleotide manufacturing service, OliGrow. We are pleased to provide our valuable customers with an expanded oligo service portfolio, additional security of supply with a second manufacturing site, as well as radiolabeling and small molecule capabilities! Explore our website to learn more about these new programs, and check back regularly for more updates.

For high quality, flexible and friendly service, count on Avecia, a Nitto Company.
Avecia News
  • Nitto Avecia is Expanding Capacity to Support Larger Scale Oligonucleotide Manufacture Read More...
  • Nitto Avecia Bolsters its Commitment to Oligonucleotide Clients in Global Markets with the Addition of Specialist Juergen Mueller Read More...
  • Nitto Denko Avecia Inc. Celebrates a Year of Strong Growth after Acquiring Girindus America’s Contract Manufacturing Business Read More...
  • Nitto Denko Avecia Inc. Strengthens its Commitment to the Small Molecule and Radiochemistry Industries by Hiring Hamilton J. Lenox as Director of Business Development Read More...
  • Nitto Denko Avecia, Inc. Introduces Dedicated Pre-Clinical Oligonucleotide Service, OliGrow Read More...
  • Nitto Denko Avecia, Inc. Acquires The Business Of Girindus America, Inc. Read More...
Avecia OliGrow News and Events Careers
For details on our small scale, pre-clinical oligo manufacturing service, click here. For the latest details about forthcoming events, click here. To view our career opportunities, click here.